Announcements Trials
Browse Landscape

Status

Available 4No longer available 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 687Observational 123Expanded_access 5

Sponsor

Cancer Type

Thoracic 8Sarcoma 7Genitourinary 5Gastrointestinal 5CNS 5Other hematologic neoplasm 4Lymphoid 4Breast 4Tumor-Agnostic 2Myeloid 2Gynecologic 2Dermatologic 2Plasma cell 1Head & Neck 1Endocrine 1

Conditions

Neurofibromatoses 1Neurofibroma, Plexiform 1Neuroblastoma 1Meningioma 1Head and Neck Neoplasms 1Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

mirdametinib 1gallium maltolate 1carbon-11 methionine 1Methionine 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Expanded_access × CNS × 90 days × Clear all
NCT05028166 2026-05-08

Individual Patient Compassionate Use of Mirdametinib

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Available
CNS

Neurofibromatoses, Neurofibroma, Plexiform

NCT05511714 2026-04-24

Expanded Access [11C] Methionine PET Imaging

St. Jude Children's Research Hospital

Available
CNSHead & Neck

Head and Neck Neoplasms, Central Nervous System Neoplasms

NCT01163383 2026-04-13

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Children's Hospital of Philadelphia

Available
CNS

Neuroblastoma

NCT07497984 2026-03-27

ITM11 Expanded Access Program

ITM Solucin GmbH

Available
CNS

Meningioma

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡